Influenza Viruses

  • Fred M. Davenport

Abstract

Epidemic influenza remains thè last great uncontrolled plague of mankind. Epidemics of influenza A and influenza B recur with monotonous frequency, and each quietly but relentlessly exacts its death toll. Periodically, worldwide pandemics levy larger and more conspicuous liens. Vaccines developed for control of influenza have been shown to be highly effective when applied to selected segments of the general population, but to date they have not been employed on a scale large enough to determine whether their use can interrupt nationwide epidemic spread. The primary strategy for partial containment of influenza has been to concentrate effort on prevention of lethal outcomes by vaccination of persons known to be at high risk. However, intensified efforts in education of the medical profession and the public concerning the importance of immunization against influenza and development of mechanisms for overcoming chronic vaccine shortages and maldistributions will be required in order to achieve a significant degree of control.(64)

Keywords

Attenuation Recombination Aspirin Tuberculosis Electrophoresis 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Anderson, T., Grist, N. R., Landsman, J. B., Laidlaw, S. I. A., and Weir, I. B. L., An epidemic of influenza due to virus B, Br. Med. J. 1:7–11 (1953).PubMedCrossRefGoogle Scholar
  2. 2.
    Andrewes, C. H., Laidlaw, P. P., and Smith, W., Influenza: Observations on the antibody content of human sera, Br. J. Exp. Pathol. 16:566–582 (1935).Google Scholar
  3. 3.
    Assaad, F., Cockburn, W. C., and Sundaresan, T. K., Use of excess mortality from respiratory diseases in the study of influenza, Bull. WHO 49:219–233 (1973).PubMedGoogle Scholar
  4. 4.
    Baron, S., and Isaacs, A., Absence of interferon in lungs from fatal cases of pneumonia, Br. Med. J. 1:18–20 (1962).PubMedCrossRefGoogle Scholar
  5. 5.
    Beare, A. S., Methods of obtaining viruses suitable for live influenza vaccines and their potential efficacy in man, in: Proceedings of the Symposium on Live Influenza Vaccine, pp. 21–29, Yugoslav Academy of Sciences and Arts, Zagreb, 1971.Google Scholar
  6. 6.
    Burnet, F. M., Influenza virus isolated from an Australian epidemic, Med. J. Aust. 2:651–653 (1935).Google Scholar
  7. 7.
    Center for Disease Control, Influenza—Respiratory Disease Surveillance, Report No. 88, p. 8, JanuaryGoogle Scholar
  8. 8.
    Center for Disease Control, Influenza—Respiratory Disease Surveillance, Report No. 89, p. 22, FebruaryGoogle Scholar
  9. 8a.
    Center for Disease Control, Influenza—Respiratory Disease Surveillance, Report No. 91, pp. 27–30, July 1977.Google Scholar
  10. 8b.
    Center for Disease Control, Influenza—Respiratory Disease Surveillance, Report No. 91, p. 2, July 1977.Google Scholar
  11. 9.
    Center for Disease Control, Mobid. Mortal. Weekly Rep. 27(13):114 (March 31, 1978).Google Scholar
  12. 9a.
    Center for Disease Control, Mobid. Mortal. Weekly Rep. 27(47):473 (Nov. 24, 1978).Google Scholar
  13. 9b.
    Center for Disease Control, Mobid. Mortal. Weekly Rep. 27(27):285–292 (Aug. 11, 1978).Google Scholar
  14. 10.
    Chang, W. K., National influenza experience in Hong Kong, Bull. WHO 41:349–351 (1968).Google Scholar
  15. 11.
    Chu, C. M., The action of normal mouse serum on influenza virus, J. Gen. Microbial. 5:739–757 (1951).Google Scholar
  16. 12.
    Collins, S. D., Influenza in the United States 1887–1956, Public Health Monograph No. 48, Government Printing Office, Washington, D.C., 1957.Google Scholar
  17. 13.
    Communicable Disease Center, Influenza—Respiratory Disease Surveillance, Report No. 82, p. 6, June 30, 1966.Google Scholar
  18. 14.
    Communicable Disease Center, Influenza Surveillance, Report No. 72, p. 10, May 31, 1962.Google Scholar
  19. 15.
    Communicable Disease Center, Influenza Surveillance, Report No. 72, Supplement, May 31, 1962.Google Scholar
  20. 16.
    Couch, R. B., Douglas, R. G., Rossen, R., and Kasel, J. A., Role of secretory antibody in influenza, in: The Secretory Immunologic System (D. H. Dayton, Jr., P. A. Small, Jr., R. M. Chanock, H. E. Kaufman, and T. B. Tomasi, eds.), pp. 93–112, National Institute of Child Health and Development, Government Printing Office, Washington, D.C., 1969.Google Scholar
  21. 17.
    Couch, R. B., Kasel, J. A., Gerin, J. L., Schulman, J. L., and Kilbourne, E. D., Induction of partial immunity to influenza by a neuraminidase-specific vaccine, J. Infect. Dis. 129:411–420 (1974).PubMedCrossRefGoogle Scholar
  22. 18.
    Czekalowski, J. W., and Prasad, A. K, Studies on influenza virus. I. Antigenic variation in influenza virus type C, Arch. Gesamte Virusforsch. 42:215–227 (1973).PubMedCrossRefGoogle Scholar
  23. 19.
    Dauer, C. C., and Serfling, R. E., Mortality from influenza 1957–1958 and 1959–1960, International Conference on Asian Influenza, Am. Rev. Respir. Dis. 83(2): Part 2, 15–26 (1961).Google Scholar
  24. 20.
    Davenport, F. M., Recent advances in prevention of influenza by vaccination, Mod. Med. 26:115–122 (1958).Google Scholar
  25. 21.
    Davenport, F. M., Pathogenesis of influenza, Conference on Airborn Infection, Bacteriol. Rev. 25:294–300 (1961).PubMedGoogle Scholar
  26. 22.
    Davenport, F. M., Killed influenza virus vaccines: Present status, suggested use, desirable developments, in: Proceedings: International Conference on the Application of Vaccines Agaist Viral, Rickettsial and Bacterial Diseases of Man, Pan American Health Organization—World Health Organization, Washington, D.C., December 14–18, 1970, pp. 85–95, PAHO Scientific Publication No. 226, 1971.Google Scholar
  27. 23.
    Davenport, F. M., Control of influenza, Symposium on Influenza, Med. J. Aust. Spec. Suppl. 1:33–38 (1973).Google Scholar
  28. 23.
    Davenport, F. M., and Hennessy, A. V., The clinical epidemiology of Asian influenza, Ann. Intern. Med. 49:493–501 (1958).PubMedGoogle Scholar
  29. 25.
    Davenport, F. M., Hennessy, A. V., Brandon, F. M., Webster, R. G., Barrett, C. D., and Lease, G. O., Comparisons of serologic and febrile responses in humans to vaccination with influenza A viruses or their hemagglutinins, J. Lab. Clin. Med. 63:5–13 (1964).PubMedGoogle Scholar
  30. 26.
    Davenport, F. M., Hennessy, A. V., Drescher, J., Mulder, J., and Francis, T., Jr., Further observations on the relevance of serologic recapitulations of human infection with influenza virus, J. Exp. Med. 120:1087–1097 (1964).PubMedCrossRefGoogle Scholar
  31. 27.
    Davenport, F. M., Hennessy, A. V., and Francis, T., Jr., Epidemiologic and immunologic significance of age distribution of antibody to antigenic variants of influenza virus, J. Exp. Med. 98:641–656 (1953).PubMedCrossRefGoogle Scholar
  32. 28.
    Davenport, F. M., Hennessy, A. V., and Minuse, E., Further observations on the significance of A/ Equine-2/63 antibodies in man, J. Exp. Med. 126:1049–1061 (1967).PubMedCrossRefGoogle Scholar
  33. 29.
    Davenport, F. M., Hennessy, A. V., Minuse, E., Maassab, H. F., Anderson, G. R., Mitchell, J. R., Heffelfinger, J. C., and Barrett, C. D., Jr., Pilot studies on mono- and bivalent live attenuated influenza virus vaccines, in: Proceedings of the Symposium on Live Influenza Vaccine, pp. 105–113, Yugoslav Academy of Sciences and Arts, Zagreb, 1971.Google Scholar
  34. 30.
    Davenport, F. M., and Minuse, E., Influenza viruses, in: Diagnostic Procedures for Viral and Rickettsial Diseases, 3rd ed. (E. H. Lennette and N. J. Schmidt, eds.), pp. 455–469, American Public Health Association, New York, 1964.Google Scholar
  35. 31.
    Davenport, F. M., Minuse, E., Hennessy, A. V., and Francis, T., Jr., Interpretations of influenza antibody patterns of man, Bull. WHO 41:453–460 (1969).PubMedGoogle Scholar
  36. 32.
    Davenport, F. M., and Monto, A. S., Practical considerations in the diagnosis of myxovirus infections, Am. J. Clin. Pathol. 57:777–782 (1972).PubMedGoogle Scholar
  37. 32a.
    Davenport, F. M., Reflections on the epidemiology of myxovirus infections, Med. Microbiol. Immunol. 164:69–76 (1977).PubMedCrossRefGoogle Scholar
  38. 33.
    Davis, D. J., Problems of allocation and distribution of influenza vaccines, International Conference on Asian Influenza, Am. Rev. Respir. Dis. 83(2): Part 2, 168–170 (1961).PubMedGoogle Scholar
  39. 34.
    Dingle, J. H., Badger, G. F., and Jordan, W. S., Jr., Illness in the Home, p. 174, The Press of Western Reserve University, Cleveland, 1964.Google Scholar
  40. 35.
    Dowdle, W. R., Coleman, M. T., Hall, E. C., and Knez, V., Properties of the Hong Kong influenza virus. 2. Antigenic relationship of the Hong Kong virus hemagglutinin to that of other human influenza A viruses, Bull. WHO 41:419–424, (1969).PubMedGoogle Scholar
  41. 36.
    Edwards, E. A., Mammen, R. E., Rosenbaum, M. J., Peckinpaugh, R. O., Mitchell, J. R., Maassab, H. F., Minuse, E., Hennessy, A. V., and Davenport, F. M., Live influenza vaccine studies in human volunteers, in: International Symposium on Influenza Vaccines for Men and Horses, London, 1972 (F. T. Perkins, London, and R. H. Regamey, Geneva, eds.), pp. 289–294, 39th Symp., Ser. Immunobiol. Standard., Vol. 20, 1973.Google Scholar
  42. 37.
    Eickhoff, T. C., Sherman, I. L., and Serfling, R. E., Observations on excess mortality associated with epidemic influenza, J. Am. Med. Assoc. 176:104–110 (1961).Google Scholar
  43. 37a.
    Evans, A. S., Niederman, J. C., and Sawyer, R. N., with the technical assistance of Wanat, J., Cenabre, L., Shepard, K., and Richards, V., Prospective studies of a group of Yale University freshmen. II. Occurrence of acute respiratory infections and rubella, J. Infect. Dis. 123:271–278 (1971).PubMedCrossRefGoogle Scholar
  44. 37b.
    Evans, A. S., Serologic studies of acute respiratory infections in military personnel, Yale J. Biol. Med. 48:201–209 (1975).PubMedGoogle Scholar
  45. 38.
    Fazekas de St. Groth, S., and Donnelly, M., The protective value of active immunization, Aust. J. Exp. Biol. Med. Sci. 28:61–75 (1950).CrossRefGoogle Scholar
  46. 39.
    Fox, J. P., and Kilbourne, E. D., Epidemiology of influenza, Summary of Influenza Workshop IV, J. Infect. Dis. 128:361–386 (1973).CrossRefGoogle Scholar
  47. 40.
    Francis, T., Jr., Transmission of influenza by a filterable virus, Science 80:457–459 (1934).PubMedCrossRefGoogle Scholar
  48. 41.
    Francis, T., Jr., Epidemiological studies in influenza, Am.J. Public Health 27:211–225 (1937).CrossRefGoogle Scholar
  49. 42.
    Francis, T., Jr., A new type of virus from epidemic influenza, Science 92:405–408 (1940).PubMedCrossRefGoogle Scholar
  50. 43.
    Francis, T., Jr., Factors conditioning resistance to epidemic influenza, Harvey Led. Ser. 37:69–99 (1941).Google Scholar
  51. 44.
    Francis, T., Jr., Influenza: The newe acquayantance, Ann. Intern. Med. 39:203–221 (1953).PubMedGoogle Scholar
  52. 45.
    Francis, T., Jr., On the doctrine of original antigenic sin, Proc. Am. Philos. Soc. 104:572–578 (1960).Google Scholar
  53. 46.
    Francis, T., Jr., and Maassab, H. F., Influenza viruses, in: Viral and Rickettsial Infections of Man, 4th ed. (F. L. Horsfall, Jr., and I. Tamm, eds.), pp. 689–740, Lippincott, Philadelphia, 1965.Google Scholar
  54. 47.
    Francis, T., Jr., Quilligan, J. J., Jr., and Minuse, E., Identification of another epidemic respiratory disease, Science 112:495–497 (1950).PubMedCrossRefGoogle Scholar
  55. 48.
    Francis, T., Jr., Salk, J. E., Pearson., H. E., and Brown, P. N., Protective effect of vaccination against induced influenza A, J. Clin. Invest. 24:536–546 (1945).PubMedCrossRefGoogle Scholar
  56. 49.
    Francis, T., Jr., Salk, J. E., and Quilligan, J. J., Jr., Experience with vaccination against influenza in the spring of 1947, Am. J. Public Health 37:1013–1016 (1947).CrossRefGoogle Scholar
  57. 50.
    Fry, J., 1961 influenza pattern, Br. Med. J. 1:745–746 (1961).CrossRefGoogle Scholar
  58. 51.
    Fukumi, H., Summary report on the Asian influenza epidemic in Japan 1957, Bull. WHO 20:187–198 (1959).PubMedGoogle Scholar
  59. 52.
    Fukumi, H., Interpretation of influenza antibody patterns in man, Bull. WHO 41:469–473 (1969).PubMedGoogle Scholar
  60. 53.
    Hall, C. E., Cooney, M. K, and Fox, J. P., The Seattle virus watch, Am. J. Epidemiol. 98:365–380 (1973).PubMedGoogle Scholar
  61. 54.
    Hennessy, A. V., Davenport, F. M., Horton, R. J. M., Napier, J. A., and Francis, T., Jr., Asian influenza: Occurrence and recurrence, a community and family study, Mil. Med. 129:38–50 (1964).PubMedGoogle Scholar
  62. 54a.
    Hennessy, A. V., Davenport, F. M., and Francis, T., Jr., Studies on antibodies to strains of influenza virus in persons of different ages in sera collected in a post epidemic period, J. Immunol. 75:401–409 (1955).PubMedGoogle Scholar
  63. 55.
    Hirsch, A., Handbook of Geographical and Historical Pathology, Vol. 1, pp. 7–17; translated from the second German edition by Charles Creighton, New Sydenham Society, London, 1883.Google Scholar
  64. 56.
    Hirst, G. K., The relationship of the receptors of a new strain of virus to those of the mumps-NDV-influenza group, J. Exp. Med. 91:177–184 (1950).PubMedCrossRefGoogle Scholar
  65. 57.
    Hobson, D., Beare, A. S., and Gardner, A. W., Haemagglutination-inhibiting serum antibody titres as an index of the response of volunteers to intranasal infection with live attenuated strains of influenza virus, in: Proceedings of the Symposium on Live Influenza Vaccine, pp. 73–84, Yugoslav Academy of Sciences and Arts, Zagreb, 1971.Google Scholar
  66. 58.
    Isaacs, A., and Hitchcock, G., Role of interferon in recovery from virus infections, Lancet 2:69–71 (1960).PubMedCrossRefGoogle Scholar
  67. 59.
    Jackson, G. G., Stanley, E. D., and Muldoon, R. L., Prospects for the control of viral diseases with chemical substances, PAHO Sci. Publ. 226:588–601 (1970).Google Scholar
  68. 60.
    Jensen, K. E., and Francis, T., Jr., The antigenic composition of influenza virus measured by antibody-absorption, J. Exp. Med. 98:619–639 (1953).PubMedCrossRefGoogle Scholar
  69. 61.
    Jordon, W. S., Jr., Denny, F. W., Jr., Badger, G. F., Curtin, C., Dingle, J. H., Oseasohn, G., and Stevens, D. A., A study of illness in a group of Cleveland families. XVII. Occurrence of Asian influenza, Am.J. Hyg. 68:190–212 (1958).Google Scholar
  70. 62.
    Kasel, J. A., Horne, E. B., Fulk, R. V., Togo, Y., Huber, M., and Hornick, R. B., Antibody responses in nasal secretions and serum of elderly persons following local or parenteral administration of inactivated influenza virus vaccine, J. Immunol. 102:555–562 (1969).PubMedGoogle Scholar
  71. 63.
    Kendal, A. P., A new receptor destroying enzyme in influenza C, in: Symposium on Neuraminidase, Behring Institute Mitteilungen, Vol. 55, pp. 18–34, Marburg, 1974.Google Scholar
  72. 64.
    Kilbourne, E. D., Chanock, R. M., Choppin, P. W., Davenport, F. M., Fox., J. P., Gregg, M. B., Jackson, G. G., and Parkman, P. D., Influenza vaccines—Summary of Influenza Workshop V, J. Infect. Dis. 129:750–771 (1974).CrossRefGoogle Scholar
  73. 65.
    Kilbourne, E. D., Choppin, P. W., Schulze, I. T., Scholtissek, C., and Bucher, D. L., Summary of Workshop I, J. Infect. Dis. 125:447–455 (1972).CrossRefGoogle Scholar
  74. 66.
    Laidlaw, P. P., Epidemic influenza: A virus disease, Lancet 1:1118–1124 (1935).CrossRefGoogle Scholar
  75. 67.
    Langmuir, A. D., Epidemiology of Asian influenza, Am. Rev. Respir. Dis. 83(2): Part 2, 2–9 (1961).Google Scholar
  76. 68.
    Langmuir, A. D., Henderson, D. A., and Serfling, R. E., The epidemiological basis for control of influenza, Am. J. Public Health 54:563–571 (1964).CrossRefGoogle Scholar
  77. 69.
    Langmuir, A. D., and Housworth, J., A critical evaluation of influenza surveillance, Bull. WHO 41:393–398 (1969).PubMedGoogle Scholar
  78. 70.
    Mackenzie, J. S., The use of temperature-sensitive mutants in live virus vaccines, in: Proceedings of the Symposium on Live Influenza Vaccine, pp. 35–41, Yugoslav Academy of Sciences and Arts, Zagreb, 1971.Google Scholar
  79. 71.
    Magill, T. P., and Francis, T., Jr., Antigenic differences in strains of human influenza virus, Proc. Soc. Exp. Biol. Med. 35:463–466 (1936).Google Scholar
  80. 72.
    Marine, W. M., and Workman, W. M., Hong Kong influenza immunologic recapitulation, Am.J. Epidemiol. 901:406–415 (1969).Google Scholar
  81. 73.
    Marine, W. M., Workman, W. M., and Webster, R. G., Immunological interrelationships of Hong Kong, Asian and Equi-2 influenza viruses in man, Bull. WHO 41:475–482 (1969).PubMedGoogle Scholar
  82. 74.
    Masurel, N., Relation between Hong Kong virus and former A2 isolates and the A/Equi/2 virus in human sera collected before 1957, Lancet 1:907–910 (1969).PubMedCrossRefGoogle Scholar
  83. 75.
    Masurel, N., Serological characteristics of a “new” serotype of influenza A virus: The Hong Kong strain, Bull. WHO 41:461–468 (1969).PubMedGoogle Scholar
  84. 76.
    Masurel, N., and Marine, W. M., Recycling of Asian and Hong Kong influenza A virus hemagglutinins in man, Am.J. Epidemiol. 97:44–49 (1973).PubMedGoogle Scholar
  85. 77.
    Masurel, N., and Mulder, J., Studies on the content of haemagglutinin-inhibiting antibody for swine influenza virus, A. Verk. Inst. Prev. Geneesk. 52:1 (1962).Google Scholar
  86. 78.
    McLean, R. L., General discussion, International Conference on Asian Influenza, Am. Rev. Respir. Dis. 83(2): Part 2, 36–38 (1961).Google Scholar
  87. 79.
    Melnick, J. L., Classification and nomenclature of animal viruses 1971, Prog. Med. Virol. 13:462–484 (1971).PubMedGoogle Scholar
  88. 80.
    Meyer, H. M., Jr, Hilleman, M. R., Miesse, M. L., Crawford, I. P., and Bankhead, A. S., New antigenic variant in Far East influenza epidemic, 1957, Proc. Soc. Exp. Biol. Med. 95:609–616 (1957).PubMedGoogle Scholar
  89. 81.
    Minuse, E., Willis, P. W., III, and Davenport, F. M., An attempt to demonstrate viremia in cases of Asian influenza, J. Lab. Clin. Med. 59:1016–1019 (1962).PubMedGoogle Scholar
  90. 82.
    Monto, A. S., Davenport, F. M., Napier, J. A., and Francis, T., Jr., Effect of vaccination of a school-age population upon the course of an A2 Hong Kong influenza epidemic, Bull. WHO 41:537–542 (1969).PubMedGoogle Scholar
  91. 83.
    Mulder, J., and Hers, J. F. P., Influenza, pp. 9–204, Wolters-Noordhoff, Groningen, The Netherlands, 1972.Google Scholar
  92. 84.
    Mulder, J., and Masurel, N., Pre-epidemic antibody against the 1957 strain of Asiatic influenza in the serum of older persons living in the Netherlands, Lancet 1:810–814 (1958).PubMedCrossRefGoogle Scholar
  93. 85.
    Murphy, B. R., Chalhub, E. G., Nusinoff, S. R., and Chanock, R. M., Temperature-sensitive mutants of influenza virus. II. Attenuation of ts recombinants for man, J. Infect. Dis. 126:170–178 (1972).PubMedCrossRefGoogle Scholar
  94. 86.
    Murphy, B. R., Chalhub, E. G., Nusinoff, S. R., Kasel, J., and Chanock, R. M., Attenuation of ts recombinants for man. III. Further characterization of ts-1 (E) influenza A recombinant (H3N2) virus in man, J. Infect. Dis. 128:479–487 (1973).PubMedCrossRefGoogle Scholar
  95. 87.
    Murray, R., Production and testing in the USA of influenza virus vaccine made from the Hong Kong variant in 1968–69, Bull. WHO 41:495–496 (1969).PubMedGoogle Scholar
  96. 88.
    Oseasohn, R., Adelson, L., and Kaji, M., Clinico-pathologic study of thirty-three fatal cases of Asian influenza, N. Engl. J. Med. 260:509–518 (1959).PubMedCrossRefGoogle Scholar
  97. 88a.
    Palese, P., and Ritchey, M. B., Poly aery lamide gel electrophoresis of the RNA’s of new influenza virus strains: An epidemiological tool, in: International Symposium on Influenza Immunization (II), Geneva, 1977 (F. T. Perkins and R. H. Regamey, Geneva, eds.), pp. 411–415, Dev. Biol. Standard., Vol. 39, S. Karger, Basel, 1977.Google Scholar
  98. 88b.
    Partin, J. C., Schubert, W., Partin, J. S., Jacobs, R., and Saalfeld, K, Isolation of influenza virus from liver and muscle biopsy specimens from a surviving case of Reye’s syndrome, Lancet 1:599–602 (1976).CrossRefGoogle Scholar
  99. 89.
    Pickles, W. N., Burnet, F. M., and McArthur, N., Epidemic respiratory infection in a rural population with special reference to the influenza A epidemics of 1933, 1936–7 and 1943–4, J. Hyg. 45:469–479 (1947).CrossRefGoogle Scholar
  100. 90.
    Plummer, N., Essential industry and its role in an influenza epidemic, International Conference on Asian Influenza, Am. Rev. Respir. Dis. 83(2): Part 2, 211–214 (1961).PubMedGoogle Scholar
  101. 90a.
    Pons, M. W., A reexamination of influenza single-and double-stranded RNA’s by gel electrophoresis, Virology 69:789–792 (1976).PubMedCrossRefGoogle Scholar
  102. 91.
    Rosenstock, I. M., Public acceptance of influenza vaccination programs, International Conference on Asian Influenza, Am. Rev. Respir. Dis. 83(2): Part 2, 171–174 (1961).PubMedGoogle Scholar
  103. 92.
    Salk, J. E., Menke, W. J., and Francis, T., Jr., A clinical, epidemiological and immunological evaluation of vaccination against epidemic influenza, Am.J. Public Health 42:57–93 (1945).Google Scholar
  104. 93.
    Salk, J. E., Pearson, H. E., Brown, P. N., and Francis, T., Jr., Protective effect of vaccination against induced influenza B, J. Clin. Invest. 24:547–553 (1945).PubMedCrossRefGoogle Scholar
  105. 94.
    Schild, G. C., Henry-Aymard, M., and Pereira, H. G., A quantitative, single-radial-diffusion test for immunological studies with influenza virus, J. Gen. Virol. 16:231–236 (1972).PubMedCrossRefGoogle Scholar
  106. 95.
    Schild, G. C., Henry-Aymard, M., Pereira, M. S., Chakraverty, P., Dowdle, W., Coleman, M., and Chang, W. K, Antigenic variation in current human type A influenza viruses: Antigenic characteristics of the variants and their geographic distribution, Bull. WHO 48:269–278 (1973).PubMedGoogle Scholar
  107. 96.
    Schild, G. C., Pereira, M. S., Chakraverty, P., Coleman, M. T., Dowdle, W. R., and Chang, W. K, Antigenic variants of influenza B virus, Br. Med. J. 4:127–131 (1973).PubMedCrossRefGoogle Scholar
  108. 97.
    Schild, G. C., and Stuart-Harris, C. H., Serologic epidemiological studies with influenza A viruses, J. Hyg. 63:479–490 (1965).CrossRefGoogle Scholar
  109. 98.
    Schulze, I. T., The structure of influenza virus: A model based on the morphology and composition of subviral particles, Virology 47:181–196 (1972).PubMedCrossRefGoogle Scholar
  110. 99.
    Serfling, R. E., Methods for current statistical analysis of excess pneumonia-influenza deaths, Public Health Rep. 78:494–506 (1963).PubMedGoogle Scholar
  111. 100.
    Sharrar, R. G., National influenza experience in the U.S.A.; 1968–69, Bull. WHO 41:361–366 (1969).PubMedGoogle Scholar
  112. 101.
    Shope, R. E., Swine influenza. III. Filtration experiments and etiology, J. Exp. Med. 54:373–385 (1931).PubMedCrossRefGoogle Scholar
  113. 102.
    Shope, R. E., The incidence of neutralizing antibodies for swine influenza virus on the sera of human beings of different ages, J. Exp. Med. 63:669–684 (1936).PubMedCrossRefGoogle Scholar
  114. 103.
    Sigel, M. M., Kitts, A. W., Light, A. B., and Henle, W., The recurrence of influenza A prime in a boarding school after 2 years, J. Immunol. 64:33–38 (1950).PubMedGoogle Scholar
  115. 104.
    Slepushkin, A. N., Schild, G. C., Be are, A. S., Chinn, S., Freestone, D., Hall, T., and Tyrrell, D. A. J., Antineuraminidase antibody and resistance to vaccination with live influenza A2 Hong Kong vaccines, in: Proceedings of the Symposium on Live Influenza Vaccine, pp. 85–92, Yugoslav Academy of Sciences and Arts, Zagreb, 1971.Google Scholar
  116. 105.
    Smith, W., Andrewes, C. H., and Laidlaw, P. P., A virus obtained from influenza patients, Lancet 2:66–68 (1933).CrossRefGoogle Scholar
  117. 106.
    Solov’ev, V. D., The results of controlled observations on the prophylaxis of influenza with interferon, Bull. WHO 41:683–688 (1969).PubMedGoogle Scholar
  118. 107.
    Stanley, E. D., and Jackson, G. G., Viremia in Asian influenza, Trans. Assoc. Am. Physicians 79:376–387 (1966).PubMedGoogle Scholar
  119. 108.
    Stuart-Harris, C. H., Influenza and Other Virus In fections of the Respiratory Tract, pp. 8–21, Williams and Wilkins, Baltimore, 1965.Google Scholar
  120. 108a.
    Stuart-Harris, Sir C. H., and Schild, G. C., Influenza: The Viruses and the Disease, p. 27, Publishing Sciences Group, Littleton, Massachusetts, 1976.Google Scholar
  121. 109.
    Stuart-Harris, Sir C. H., Pandemic influenza: An unresolved problem in prevention, J. Infect. Dis. 122:108–115 (1970).PubMedCrossRefGoogle Scholar
  122. 110.
    Stuart-Harris, Sir C. H., Control of influenza, lack of knowledge versus lack of application of knowledge, Arch. Environ. Health 21:276–284 (1970).PubMedGoogle Scholar
  123. 111.
    Taylor, R. M., A further note on 1233 (“influenza C”) virus, Arch. Gesamte Virusforsch. 4:485–500 (1951).PubMedCrossRefGoogle Scholar
  124. 112.
    Thomson, D., and Thomson, R., Influenza, Ann. Pickett-Thomson Res. Lab. 9:4 (1933).Google Scholar
  125. 113.
    Tyrrell, D. A. J., and Beare, A. S., Live influenza virus vaccines: An interim report, Pan Am. Health Organ. Sci. Publ. 226:96–100 (1971).Google Scholar
  126. 113a.
    Tyrrell, D. A. J., Using the genetics of influenza virus to make live attenuated vaccines, Lancet 1:196–197 (1978).PubMedCrossRefGoogle Scholar
  127. 114.
    Waldman, R. H., Bond, J. O., Levitt, L. P., Hartwig, E. C., Prather, E. C., Baratta, R. L., Neill, J. S., and Small, P. A., Jr., An evaluation of influenza immunization: Influence of route of administration and vaccine strain, Bull. WHO 41:543–548 (1969).PubMedGoogle Scholar
  128. 115.
    Waldman, R. H., Small, P. A., Jr., and Rowe, D. S., Utilization of the secretory immunologic system for protection against disease, in: The Secretory Immunologic System (D. H. Dayton, Jr., P. A. Small, Jr., R. M. Chanock, H. E. Kaufman, and T. B. Tomasi, eds.), pp. 129–147, National Institute of Child Health and Development, Government Printing Office, Washington, D.C., 1969.Google Scholar
  129. 116.
    Widelock, D., Klein, S., Peizer, L. R., and Simonovic, O., A laboratory analysis of 1957–1958 influenza outbreak in New York City. II. A seroepide- miological study, Am.J. Public Health 49:847–856 (1959).CrossRefGoogle Scholar
  130. 117.
    Zakstelskaya, L. Y., Recovery of the virus from the urine of patients with epidemic influenza, Gupp: OKUDR Trans. Ob’jed. Sess. Inst. AMN SSSR, Moscow, 72 (1953).Google Scholar
  131. 118.
    Zakstelskaja, L. Y., Evstigneeva, N. A., Isachenko, V. A., Shenderovitch, S. P., and Efimova, V. A., Influenza in the USSR: New antigenic variant A2/ Hong Kong/1/68 and its possible precursors, Am.J. Epidemiol. 90:400–405 (1969).PubMedGoogle Scholar
  132. 119.
    Zhdanov, V. M., Solov’ev, V. D., and Epshtein, F. G., The Study of Influenza: Epidemiology, pp. 648–732, Russian Scientific Translation Program, Division of General Medical Sciences, National Institutes of Health, Bethesda, Maryland, 1960.Google Scholar

Suggested Reading

  1. Fox, J. P., and Kilbourne, E. D., Epidemiology of influenza, Summary of Influenza Workshop IV, J. Infect. Dis. 128:361–386 (1973).CrossRefGoogle Scholar
  2. Francis, T., Jr., and Maassab, H. F., Influenza viruses in: Viral and Rickettsial Infections of Man, 4th ed. (F. L. Horsfall, Jr., and I. Tamm, eds.), pp. 689–740, Lippincott, Philadelphia, 1965.Google Scholar
  3. Hoyle, L., The Influenza Viruses, Springer-Verlag, New york, 1968.Google Scholar
  4. Kilbourne, E. D., The Influenza Viruses and Influenza, Academic Press, New York, 1975.Google Scholar
  5. Stuart-Harris, Sir C. H., and Schild, G. C, Influenza: The Viruses and the Disease, Publishing Sciences Group, Littleton, Massachusetts, 1976.Google Scholar
  6. Beveridge, W. D., Influenza: The Last Great Plague, Prodest, New york, 1977.Google Scholar
  7. Crosby, A. W., Jr., Epidemic and Peace, 1918, Greenwood Press, Westport, Connecticut, 1976.Google Scholar

Copyright information

© Plenum Publishing Corporation 1982

Authors and Affiliations

  • Fred M. Davenport
    • 1
  1. 1.Department of Epidemiology, School of Public HealthUniversity of MichiganAnn ArborUSA

Personalised recommendations